Literature DB >> 27354925

Medical Marijuana for Epilepsy?

Murali K Kolikonda1, Kavitha Srinivasan1, Manasa Enja1, Vishwanath Sagi1, Steven Lippmann1.   

Abstract

Treatment-refractory epilepsy remains an important clinical problem. There is considerable recent interest by the public and physicians in using medical marijuana or its derivatives to treat seizures. The endocannabinoid system has a role in neuronal balance and ictal control. There is clinical evidence of success in diminishing seizure frequencies with cannabis derivatives, but also documentation about exacerbating epilepsy or of no discernible effect. There are lay indications and anecdotal reports of success in attenuating the severity of epilepsy, but without solid investigational corroboration. Marijuana remains largely illegal, and may induce adverse consequences. Clinical applications are not approved, thus are restricted and only recommended in selected treatment unresponsive cases, with appropriate monitoring.

Entities:  

Keywords:  Charlotte’s Web; Doose syndrome; Dravet syndrome; Lennox-Gestaut; Marijuana; cannabidiol; convulsions; endocannabinoid system; epilepsy; ictus; medical marijuana; seizures; treatment unresponsive epilepsy

Year:  2016        PMID: 27354925      PMCID: PMC4911937     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  25 in total

1.  The case for medical marijuana in epilepsy.

Authors:  Edward Maa; Paige Figi
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

Review 2.  Pharmacology of cannabinoid CB1 and CB2 receptors.

Authors:  R G Pertwee
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

3.  Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey.

Authors:  Gary W Mathern; Laurie Beninsig; Astrid Nehlig
Journal:  Epilepsia       Date:  2014-11-20       Impact factor: 5.864

Review 4.  Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.

Authors:  Mackenzie E Hofmann; Charles J Frazier
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

Review 5.  The pharmacologic and clinical effects of medical cannabis.

Authors:  Laura M Borgelt; Kari L Franson; Abraham M Nussbaum; George S Wang
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

6.  Seizure exacerbation in two patients with focal epilepsy following marijuana cessation.

Authors:  Manu Hegde; Carlos Santos-Sanchez; Christopher P Hess; Arif A Kabir; Paul A Garcia
Journal:  Epilepsy Behav       Date:  2012-11-13       Impact factor: 2.937

7.  Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center.

Authors:  D W Gross; J Hamm; N L Ashworth; D Quigley
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

Review 8.  Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.

Authors:  Jerzy P Szaflarski; E Martina Bebin
Journal:  Epilepsy Behav       Date:  2014-10-01       Impact factor: 2.937

9.  Late onset epilepsy associated with marijuana abuse: a case report with MRI findings.

Authors:  Yannick Fogoum Fogang; Massaman Camara; Paul Chimi Mbonda; Dènahin Toffa; Kamadore Touré
Journal:  Pan Afr Med J       Date:  2014-03-04

Review 10.  Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review.

Authors:  Shaheen E Lakhan; Marie Rowland
Journal:  BMC Neurol       Date:  2009-12-04       Impact factor: 2.474

View more
  3 in total

1.  MARIJUANA ON THE BRAIN- A CONCERN.

Authors:  Shivani Naik; Murali Kolikonda; Angeline Prabhu; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2018-02-01

Review 2.  Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.

Authors:  Douglas L Boggs; Jacques D Nguyen; Daralyn Morgenson; Michael A Taffe; Mohini Ranganathan
Journal:  Neuropsychopharmacology       Date:  2017-09-06       Impact factor: 7.853

3.  Recurrent seizures from chronic kratom use, an atypical herbal opioid.

Authors:  William O Tatum; Tasneem F Hasan; Erin E Coonan; Christopher P Smelick
Journal:  Epilepsy Behav Case Rep       Date:  2018-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.